Sunday, January 26, 2020

Biocon Biologics eyes $200M, plans IPO in 2 years: Kiran Mazumdar-Shaw

With the funding, Biocon is looking to fund its research and development, and infuse capital to expand its biosimilars business https://ift.tt/37uXTvM https://ift.tt/eA8V8J

No comments:

Post a Comment

Docs: Israeli AI chip startup Hailo is pursuing an urgent IPO via a SPAC merger at a valuation of less than $500M; it was last valued at $1.2B in 2024 (Meir Orbach/CTech)

Meir Orbach / CTech : Docs: Israeli AI chip startup Hailo is pursuing an urgent IPO via a SPAC merger at a valuation of less than $500M; ...